Literature DB >> 32525054

Prospective Impact of Sildenafil on Chronic cEntral Serous Chorioretinopathy: PISCES Trial.

Mark P Breazzano1, D Jackson Coleman2, Royce W S Chen3, Stanley Chang3, Suzanne Daly3, Stephen H Tsang4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32525054      PMCID： PMC7739868          DOI： 10.1016/j.oret.2020.06.006

Source DB:  PubMed          Journal:  Ophthalmol Retina        ISSN： 2468-6530


× No keyword cloud information.
  7 in total

1.  The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography.

Authors:  Sushma K Vance; Yutaka Imamura; K Bailey Freund
Journal:  Retina       Date:  2011-02       Impact factor: 4.256

2.  Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: A randomized controlled multicenter clinical trial.

Authors:  Patrizio Vitulo; Anna Stanziola; Marco Confalonieri; Daniela Libertucci; Tiberio Oggionni; Paola Rottoli; Giuseppe Paciocco; Fabio Tuzzolino; Lavinia Martino; Marta Beretta; Adriana Callari; Andrea Amaducci; Roberto Badagliacca; Roberto Poscia; Federica Meloni; Rosa Metella Refini; Pietro Geri; Sergio Baldi; Stefano Ghio; Michele D'Alto; Paola Argiento; Matteo Sofia; Mara Guardamagna; Beatrice Pezzuto; Carmine Dario Vizza
Journal:  J Heart Lung Transplant       Date:  2016-05-07       Impact factor: 10.247

3.  One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.

Authors:  Ichiro Maruko; Tomohiro Iida; Yukinori Sugano; Minoru Furuta; Tetsuju Sekiryu
Journal:  Retina       Date:  2011-10       Impact factor: 4.256

Review 4.  Central serous chorioretinopathy: Towards an evidence-based treatment guideline.

Authors:  Thomas J van Rijssen; Elon H C van Dijk; Suzanne Yzer; Kyoko Ohno-Matsui; Jan E E Keunen; Reinier O Schlingemann; Sobha Sivaprasad; Giuseppe Querques; Susan M Downes; Sascha Fauser; Carel B Hoyng; Felice Cardillo Piccolino; Jay K Chhablani; Timothy Y Y Lai; Andrew J Lotery; Michael Larsen; Frank G Holz; K Bailey Freund; Lawrence A Yannuzzi; Camiel J F Boon
Journal:  Prog Retin Eye Res       Date:  2019-07-15       Impact factor: 21.198

5.  Choroidal Vascular Reactivity in Central Serous Chorioretinopathy.

Authors:  Felice Cardillo Piccolino; Marco Lupidi; Carlo Cagini; Daniela Fruttini; Massimo Nicolò; Chiara Maria Eandi; Silvia Tito
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-08-01       Impact factor: 4.799

6.  Central serous chorioretinopathy and phosphodiesterase-5 inhibitors: a case-control postmarketing surveillance study.

Authors:  Dustin D French; Curtis E Margo
Journal:  Retina       Date:  2010-02       Impact factor: 4.256

7.  Treatment of Macular Degeneration with Sildenafil: Results of a Two-Year Trial.

Authors:  D Jackson Coleman; Winston Lee; Stanley Chang; Ronald H Silverman; Harriet O Lloyd; Suzanne Daly; Stephen H Tsang
Journal:  Ophthalmologica       Date:  2018-04-25       Impact factor: 3.250
  7 in total
  3 in total

Review 1.  Pathophysiology of central serous chorioretinopathy: a literature review with quality assessment.

Authors:  Pushpinder Kanda; Arnav Gupta; Chloe Gottlieb; Rustum Karanjia; Stuart G Coupland; Manpartap Singh Bal
Journal:  Eye (Lond)       Date:  2021-10-15       Impact factor: 4.456

2.  Risk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US.

Authors:  Mahyar Etminan; Mohit Sodhi; Frederick S Mikelberg; David Maberley
Journal:  JAMA Ophthalmol       Date:  2022-05-01       Impact factor: 8.253

3.  New COL6A6 Variant Causes Autosomal Dominant Retinitis Pigmentosa in a Four-Generation Family.

Authors:  Veronika Vaclavik; Leila Tiab; Young Joo Sun; Vinit B Mahajan; Alexandre Moulin; Nathalie Allaman-Pillet; Francis L Munier; Daniel F Schorderet
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-03-02       Impact factor: 4.925
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.